For six months, bears argued that every concession Lilly made on price would bleed margin faster than volume could refill it
16 The agencies pointed out 17 that commenters also noted that enabling States to more easily and, perhaps, therefore, more frequently, update their EHB-benchmark plans could result in expanded coverage for, among other things, maternity care, substance use disorder care, obesity care, and chronic disease management. So while most current EHB benchmark plans do not include coverage for anti-obesity medications, that could certainly change in the coming years
Based on these failures, FDA has concerns about the quality and integrity of the data generated from the nonclinical laboratory studies conducted at your testing facility
How Long Does Fatigue from GLP-1 Medications Last
Darsalia et al., 2014a